SEP 4, 2026 · JOURNAL ARTICLE
Real-World Treatment Patterns and Clinical Outcomes After First-Line Therapy in Patients with KRAS G12C-Mutant Advanced Non-Small-Cell Lung Cancer in the United States
Cancers
Retrospective real-world observational study without randomisation or concurrent control arms; provides outcome descriptors and treatment patterns but cannot establish comparative efficacy or causality for treatment strategies.
Reported
Sample size (EHR)1227
Sample size (CGDB)447
Median OS overall (EHR)17.0 months (95% CI 15.2–18.9)